SCHEMBL5843589

SCHEMBL5843589

Nc1ncccc1OCCCc1ccc(Cl)cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR4 O95977 4/20 0.49
MAPT P10636 3/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 1/20 0.49
L3MBTL1 Q9Y468 4/20 0.45
LMNA P02545 2/20 0.45
TSHR P16473 1/20 0.45
MAPK1 P28482 1/20 0.45
BACE1 P56817 1/20 0.44
TDP1 Q9NUW8 4/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
HTT P42858 1/20 0.43
PPP1CA P62136 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HPGD P15428 1/20 0.43
LTA4H P09960 1/20 0.42
MAPK14 Q16539 1/20 0.42
PDE4A P27815 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4C Q08493 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16554687 0.93 S1PR4 (0.50) S1PR4MAPTNPC1RAB9AL3MBTL1
SCHEMBL488869 0.85 NPC1 (0.59) S1PR4MAPTNPC1RAB9AL3MBTL1
SCHEMBL15779024 0.82 NPC1 (0.53) S1PR4MAPTNPC1RAB9AL3MBTL1
SCHEMBL5844385 0.77 SLC2A1 (0.52) S1PR4MAPTNPC1RAB9ALMNA
SCHEMBL9125686 0.76 NPC1 (0.63) S1PR4MAPTNPC1RAB9AL3MBTL1
SCHEMBL15779243 0.74 NPC1 (0.42) S1PR4MAPTNPC1RAB9AL3MBTL1
SCHEMBL7843486 0.74 LTA4H (0.56) S1PR4MAPTNPC1RAB9ALMNA
SCHEMBL28380651 0.73 NPC1 (0.52) S1PR4MAPTNPC1RAB9AMAPK1
SCHEMBL7844990 0.73 LTA4H (0.54) S1PR4MAPTNPC1RAB9ALMNA
SCHEMBL15779490 0.73 NPC1 (0.51) S1PR4MAPTNPC1RAB9ABACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7105534-B2 Imidazo[1,2-α]pyridine ether compounds as ion channel modulators CARDIOME PHARMA CORP. (CA) 2006-09-12 US disclosed
US-20040048885-A1 Imidazo[1,2,-A]pyridine ether compounds as ion channel modulators CORREVIO CANADA CORP. (CA) 2004-03-11 US disclosed
WO-2001096335-A1 IMIDAZO[1,2-A]PYRIDINE ETHER COMPOUNDS AS ION CHANNEL MODULATORS CARDIOME PHARMA CORP. (CA) 2001-12-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040048885-A1 Imidazo[1,2,-A]pyridine ether compounds as ion channel modulators KCNJ2, KCNH2, KCNA1 S1PR4 2415/4885MAPT 4682/4885NPC1 1322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.